clotrimazole has been researched along with ergosterol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Voigt, WH | 1 |
| Kozený, M; Latinák, J; Lenhart, K; Merkunová, A; Walterová, D | 1 |
| Dix, BA; Freudenberger, J; Funke, PT; Georgopapadakou, NH; Smith, SA | 1 |
| Gorman, SP; Millership, JS; Scott, EM; Wright, LR | 1 |
| Haller, I | 1 |
| Feingold, DS; Sud, IJ | 2 |
| Hamada, T; Nikawa, H; Samaranayake, LP; Tenovuo, J | 1 |
| Botes, PJ; Ells, R; Kock, JL; Pohl, CH; Van Wyk, PW | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG | 1 |
| Fang, Y; Hu, L; Jaiseng, W; Kuno, T; Takami, T; Zhang, B; Zhou, X | 1 |
| Bracher, F; Kießling, J; Krauss, J; Müller, C; Richter, S; Staudacher, V | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AG | 1 |
| Balamurugan, K; Iyer, PM; Pandian, SK; Subramenium, GA; Swetha, TK | 1 |
| Acharya, D; Goswami, D; Patel, SK; Poojara, L; Prajapati, J; Rao, P; Rawal, RM | 2 |
17 other study(ies) available for clotrimazole and ergosterol
| Article | Year |
|---|---|
On the mode of action of antimycotics, especially of clotrimazole (Canesten), on the ultrastructural level of human pathogenic fungi.
Topics: Antifungal Agents; Cell Membrane; Clotrimazole; Cytoplasm; Ergosterol; Female; Fungi; Humans; Imidazoles; Organoids | 1978 |
Ketoconazole-resistant mutants of Microsporum gypseum. II. Characteristics of mutants.
Topics: Clotrimazole; Drug Resistance, Microbial; Ergosterol; Ketoconazole; Miconazole; Microsporum; Mutation | 1989 |
Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.
Topics: Allylamine; Animals; Antifungal Agents; Candida albicans; Cell Membrane; Cerulenin; Cholestadienols; Chromatography, Gas; Chromatography, Thin Layer; Clotrimazole; Culture Techniques; Econazole; Ergosterol; Fatty Acids; Ketoconazole; Lipids; Miconazole; Tolnaftate | 1987 |
Effect of miconazole and clotrimazole on K+ release and inhibition of ergosterol biosynthesis in Trichophyton mentagrophytes and related ultrastructural observations.
Topics: Cell Membrane Permeability; Clotrimazole; Ergosterol; Imidazoles; Intracellular Fluid; Miconazole; Potassium; Trichophyton | 1986 |
Mode of action of clotrimazole: implications for therapy.
Topics: Azoles; Candida albicans; Clotrimazole; Culture Media; Ergosterol; Female; Humans; Imidazoles; Microbial Sensitivity Tests; Microscopy, Electron; Structure-Activity Relationship; Time Factors | 1985 |
Heterogeneity of action of mechanisms among antimycotic imidazoles.
Topics: Aerobiosis; Anaerobiosis; Antifungal Agents; Clotrimazole; Ergosterol; Imidazoles; Ketoconazole; Lanosterol; Miconazole; Piperazines; Saccharomyces cerevisiae | 1981 |
Mechanisms of action of the antimycotic imidazoles.
Topics: Clotrimazole; Dose-Response Relationship, Drug; Ergosterol; Imidazoles; Lanosterol; Miconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae | 1981 |
The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
Topics: Amphotericin B; Antifungal Agents; Apoproteins; Candida albicans; Cell Death; Cell Wall; Clotrimazole; Drug Resistance, Microbial; Ergosterol; Flucytosine; Lactoferrin; Membrane Glycoproteins; Miconazole; Nystatin; Tunicamycin | 1994 |
Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Arachidonic Acid; Biofilms; Candida; Cell Membrane; Clotrimazole; Drug Synergism; Ergosterol; Microbial Viability; Phospholipids | 2009 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole | 2010 |
A genomewide screen in Schizosaccharomyces pombe for genes affecting the sensitivity of antifungal drugs that target ergosterol biosynthesis.
Topics: Antifungal Agents; Cell Membrane; Cell Wall; Cellulase; Chromatography, High Pressure Liquid; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Gene Deletion; Genetic Complementation Test; Genome-Wide Association Study; Histones; Microbial Sensitivity Tests; Naphthalenes; Schizosaccharomyces; Signal Transduction; Terbinafine; Ubiquitination | 2012 |
Synthesis and biological evaluation of novel N-alkyl tetra- and decahydroisoquinolines: novel antifungals that target ergosterol biosynthesis.
Topics: Antifungal Agents; Clotrimazole; Ergosterol; Fungi; Isoquinolines; Microbial Sensitivity Tests; Structure-Activity Relationship | 2014 |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
Topics: Antifungal Agents; Clotrimazole; Cryptococcus; Enzyme Activation; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Lanosterol; Pyridines; Sterol 14-Demethylase; Tetrazoles; Voriconazole | 2016 |
5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans.
Topics: Animals; Antifungal Agents; Bacillus subtilis; Biofilms; Caenorhabditis elegans; Candida albicans; Clotrimazole; Drug Synergism; Ergosterol; Furaldehyde; Hyphae; Ketoconazole; Miconazole; Virulence | 2018 |
Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae.
Topics: Amino Acid Sequence; Antifungal Agents; Clotrimazole; Curcumin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ergosterol; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Phylogeny; Protein Binding; Rhizopus oryzae | 2021 |
A Comprehensive in vitro and in silico Assessment on Inhibition of CYP51B and Ergosterol Biosynthesis by Eugenol in Rhizopus oryzae.
Topics: Antifungal Agents; Clotrimazole; Ergosterol; Eugenol; Heme; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mucormycosis; Rhizopus; Rhizopus oryzae | 2022 |